PushWith this bit of upward this morning I think all we need is more positives from the Company regarding marketing the Reducer and we'll see a stronger move to close that gap. This company has huge potential particularly with its product, Reducer, currently demonstrating efficacy in Europe and close to CEMark close to granting marketing rights.
"We have three specific tasks to focus on, in order to recognize the potential of our Tiara and Reducer products. Our goal is to expand on the foundation we established in Europe and on the growing enthusiasm in the market for the Reducer therapy, based on the initial, promising clinical experiences. We also remain pleased with the clinical results to-date from the first 50 Tiara implants, with ongoing enrollment in our Tiara I and II studies, as well as the initiation of the development of the transfemoral, trans-septal version of Tiara," concluded Colen.